Clinical Trial Specialist

Morphosys Boston , MA 02298

Posted 3 weeks ago

Clinical Trial Specialist

  • Boston, MA

Company Background

MorphoSys is focused on creating significant value for all of its stakeholders through a strategy that balances short- and long-term growth potential along with a focus on our customers. We are dedicated to bringing breakthrough medicines in oncology to market to help address unmet needs for patients with serious diseases. By applying our proprietary technologies, MorphoSys has become a world leader in the field of therapeutic antibodies. The company has established successful and lasting partnerships with industry-leading companies from the pharmaceutical and biotechnology sectors. For example, we recently entered into a global collaboration and license agreement with Incyte Corporation to further develop and commercialize MorphoSys' lead investigational asset.

The product pipeline, one of the broadest in the biotech industry, includes over 100 distinct investigational drugs, and more than 25 therapeutic antibodies in clinical trials. This foundation combining high science and innovative technology elevates the standards for how antibodies will be made in the future enabling their use as research, diagnostic, and therapeutic tools.

Through specific in-licensing and co-development activities of our own, and in conjunction with our partners, the company is adding higher value programs to the pipeline at a significant rate. Our comprehensive partnering strategy is an important feature of our business model, and a vital source of MorphoSys' financial strength.

To advance the development of Tafasitamab and in preparation for its planned commercialization MorphoSys founded MorphoSys US Inc., a wholly owned subsidiary of MorphoSys AG, and raised independent funding by successfully closing an IPO on the Nasdaq U.S. stock exchange in April 2018. Our focused, controlled growth and commercialization journey has been substantial starting in 2018 with our US IPO and culminating in our Incyte Corporation partnership in 2020. These three years have been important for MorphoSys as we continue to strive to deliver innovative medicines to patients who need them. The company is realizing our goal of becoming a fully integrated global biopharmaceutical company.

Tafasitamab is an investigational, Fc-engineered therapeutic antibody targeting CD19 that is in development for the treatment of B cell malignancies. The focus of the development program is on relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL), a particularly aggressive form of lymphoma. Tafasitamab received a breakthrough therapy designation (BTD) from the FDA in 2017 based on preliminary data from the phase 2 L-MIND study, which is evaluating the safety and efficacy of Tafasitamab in combination with lenalidomide. MorphoSys published the final L-MIND data in May 2019, and filed the BLA for Tafasitamab with the FDA in December 2019 which got accepted on March 2nd, 2020 with a priority review status.

Job Summary & General Responsibilities

The Clinical Trial Specialist is responsible for supporting all aspects of operational activities of phase I-IV clinical trial(s) from planning through close-out as assigned under the leadership of the Clinical Trial Leader (CTL).

General Accountabilities

Provides support to the CTL in:

  • Organizing Clinical Trial Team (CTT) meetings and prepare meeting minutes

  • Tracking and following up on outstanding actions from the CTT meetings

  • Ensuring all operational trial deliverables as assigned are met according to timelines, budget, operational procedures and quality standards

  • Preparing outsourcing specifications and in the follow up with day to day operation with vendors

  • Managing in-house Trial Master File (TMF) and ensuring implementation of TMF management plan and QC plan

  • Managing interactions with the CTT and Vendors

  • Coordinating of activities to set-up trial-related systems and documents leading to site initiation

  • Planning investigator meetings or equivalent investigator training and monitor trainings

  • Collecting and tracking trial status such as enrollment, timelines and data entry/queries for updating the relevant internal/external boards

  • Ensuring accuracy of trial information in all trial databases, TMF, and tracking systems

  • Initiating trial close out activities and ensuring completion of final drug accountability

  • Ensures inspection/audit readiness including TMF documentation and participates in internal audits and inspections as required

  • Contributes to process improvement or acts as Subject Matter Experts for training or SOPs

  • Coaches new CTSs during their onboarding as assigned

Job Qualifications, Experience & Skills

  • Bachelor's degree or equivalent qualification in life science/healthcare

  • Min. 3 years clinical trial support experience required

  • Previous involvement with clinical study development, implementation or reporting activities preferred

  • Good communication, organization and tracking skills

  • Good knowledge of Good Clinical Practice

  • Familiar with clinical trial and drug development process

  • Ability to work in a matrix organization and demonstrates collaboration skills

  • Ability to work under pressure

  • Effectively prioritizes workload

  • Fluent English (oral and written)

Location

  • Boston, MA
icon no score

See how you match
to the job

Find your dream job anywhere
with the LiveCareer app.
Mobile App Icon
Download the
LiveCareer app and find
your dream job anywhere
App Store Icon Google Play Icon
lc_ad

Boost your job search productivity with our
free Chrome Extension!

lc_apply_tool GET EXTENSION

Similar Jobs

Want to see jobs matched to your resume? Upload One Now! Remove
Clinical Trial Manager

Morphosys

Posted 1 week ago

VIEW JOBS 3/26/2020 12:00:00 AM 2020-06-24T00:00 Clinical Trial Manager * Boston, MA Company Background MorphoSys is focused on creating significant value for all of its stakeholders through a strategy that balances short- and long-term growth potential along with a focus on our customers. We are dedicated to bringing breakthrough medicines in oncology to market to help address unmet needs for patients with serious diseases. By applying our proprietary technologies, MorphoSys has become a world leader in the field of therapeutic antibodies. The company has established successful and lasting partnerships with industry-leading companies from the pharmaceutical and biotechnology sectors. For example, we recently entered into a global collaboration and license agreement with Incyte Corporation to further develop and commercialize MorphoSys' lead investigational asset. The product pipeline, one of the broadest in the biotech industry, includes over 100 distinct investigational drugs, and more than 25 therapeutic antibodies in clinical trials. This foundation combining high science and innovative technology elevates the standards for how antibodies will be made in the future enabling their use as research, diagnostic, and therapeutic tools. Through specific in-licensing and co-development activities of our own, and in conjunction with our partners, the company is adding higher value programs to the pipeline at a significant rate. Our comprehensive partnering strategy is an important feature of our business model, and a vital source of MorphoSys' financial strength. To advance the development of Tafasitamab and in preparation for its planned commercialization MorphoSys founded MorphoSys US Inc., a wholly owned subsidiary of MorphoSys AG, and raised independent funding by successfully closing an IPO on the Nasdaq U.S. stock exchange in April 2018. Our focused, controlled growth and commercialization journey has been substantial starting in 2018 with our US IPO and culminating in our Incyte Corporation partnership in 2020. These three years have been important for MorphoSys as we continue to strive to deliver innovative medicines to patients who need them. The company is realizing our goal of becoming a fully integrated global biopharmaceutical company. Tafasitamab is an investigational, Fc-engineered therapeutic antibody targeting CD19 that is in development for the treatment of B cell malignancies. The focus of the development program is on relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL), a particularly aggressive form of lymphoma. Tafasitamab received a breakthrough therapy designation (BTD) from the FDA in 2017 based on preliminary data from the phase 2 L-MIND study, which is evaluating the safety and efficacy of Tafasitamab in combination with lenalidomide. MorphoSys published the final L-MIND data in May 2019, and filed the BLA for Tafasitamab with the FDA in December 2019 which got accepted on March 2nd, 2020 with a priority review status. Job Summary & General Responsibilities The Clinical Trial Manager is accountable for providing oversight to the site management activities of phase I-IV clinical trials outsourced to a vendor i.e. Contract Research Organization (CRO) from trial planning and site feasibility through study close-out, in compliance with MorophoSys processes, ICH GCP and regulatory requirements. General Accountabilities * Maintains a strong knowledge of the protocol to be able to answer operational questions from CRO Site Management Team (i.e. Clinical Trial Managers/Lead Clinical Research Associates (CTMs/Lead CRAs) and Clinical Research Associates (CRAs) and investigator sites * Recognizes potential challenge within the protocol and operational aspects of the trial and escalates to Clinical Trial Leader (CTL) for development of appropriate actions if required * Contributes to the development of trial execution plan and supports trial feasibility * Trains CRO Site Management Team on the protocol and key trial elements together with CTL for performing site selection * Recommends list of sites for trial participation to Clinical Trial Team (CTT) * Develops and implements site management oversight plan * Monitors the progress of site selection and site initiation visits * Works with CRO Site Management Team and ensures that all essential documents are in place for approval of site initiation and release of Investigational Medicinal Products (IMP) to the sites * Provides training as needed to the CRO Site Management Team and any other activities that support site readiness to recruit * Ensures monitoring visits are performed by CRO CRA according to the monitoring plan * Reviews site issues and relevant monitoring visit reports to identify quality/compliance issues that require escalation to CTL and/or require follow-up with the CRO Site Management Team for resolution with the sites * Performs co-monitoring visits with the CRO CRA as required * Performs periodic review of protocol deviations and issues to identify any trends for communicating and taking appropriate actions with CTL and/or Quality Assurance * Provides governance on country and site-specific TMFs maintained by the CRO Site Management Team * Communicates with CRO Site Management Team on a regular basis to assure proper adherence to protocol, timelines and other trial related topics * Serves as main contact to CRO Site Management Team for any potentially significant quality/compliance issues and escalates to CTT as required * Attends and participates in CTT meetings * Reviews and communicates with CRO Site Management Team to ensure timely CRF data entry and resolution of data issues by the sites * Ensures that all trial close-out activities are performed, in close cooperation with CRO Site Management Team and CTL * Participates in internal audits and HA inspections as required * Leads or actively contributes to process improvement or acts as Subject Matter Experts for training or SOPs * Coaches new CTMs during their onboarding as assigned Job Qualifications, Experience & Skills * Bachelor's degree or equivalent qualification in life science/healthcare * Master degree is preferred * >5 years pharmaceutical industry experience with 3-5 years strong experience in clinical research in a field monitor role or a role overseeing clinical trials * Thorough knowledge of Good Clinical Practice, regulatory processes, and clinical trial process * Experience with health authority inspections (FDA and/or EMA) preferred * Strong Interpersonal skills * Strong Project Management and leadership skills * Working experience in a global team, team player * Ability to work under pressure * Ability to work in a matrix environment * Displays innovative ideas and solutions * Highly proficient in negotiation skills * Highly effective in influencing others * Fluent English (oral and written) Location * Boston, MA Morphosys Boston MA

Clinical Trial Specialist

Morphosys